BeiGene Ltd.

NASDAQ: BGNE · Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM

BeiGene Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.18B 3.81B 3.32B 3.1B 2.76B 2.46B 2.2B 1.81B 1.56B 1.42B 1.25B 1.07B 877.04M 1.18B 1.06B 947.04M 862.69M
Cost of Revenue
634.16M 594.09M 539.36M 465.21M 845.83M 1.21B 1.62B 2.03B 1.96B 1.93B 1.89B 1.78B 1.73B 1.62B 1.52B 1.49B 1.4B
Gross Profit
3.54B 3.22B 2.78B 2.63B 1.92B 1.25B 579.48M -220.79M -405.11M -511.06M -636.66M -714.29M -848.85M -447.86M -459.33M -545.53M -537.81M
Operating Income
-295.75M -568.2M -872.57M -886.27M -1.1B -1.21B -1.29B -1.6B -1.72B -1.79B -1.89B -1.92B -1.95B -1.44B -1.35B -1.33B -1.21B
Interest Income
31.68M 47.84M 61.01M 77.01M 78.86M 78.71M 92.53M 78.64M 75M 69.06M 34.26M 21.5M 10.07M n/a n/a n/a 1.11M
Pretax Income
-268.68M -533M -798.42M -470.78M -732.32M -825.84M -906.03M -1.69B -1.88B -1.96B -2.12B -2B -1.92B -1.44B -1.33B -1.34B -1.19B
Net Income
-392.37M -644.79M -3.15B -2.81B -3.07B -3.17B -3.68B -4.46B -4.65B -4.73B -2.15B -2.01B -1.91B -1.41B -1.3B -1.31B -1.17B
Selling & General & Admin
1.86B 1.83B 1.74B 1.65B 1.6B 1.5B 1.42B 1.38B 1.31B 1.28B 1.26B 1.2B 1.1B 990.12M 891.83M 783.44M 675.2M
Research & Development
1.97B 1.95B 1.91B 1.86B 1.83B 1.78B 1.73B 1.7B 1.66B 1.64B 1.62B 1.55B 1.53B 1.46B 1.38B 1.38B 1.31B
Other Expenses
n/a 1.76M 1.76M 1.76M -62.06M -63.63M -63.44M -63.26M 750K 751K -10.02M 21.27M 20.21M 15.9M 34.61M 8.84M 29.69M
Operating Expenses
3.84B 3.78B 3.65B 3.52B 3.01B 2.46B 1.87B 1.38B 1.31B 1.28B 1.26B 1.2B 1.1B 990.87M 892.58M 784.19M 675.95M
Interest Expense
n/a n/a 4.71M 4.71M 4.71M 4.71M 16.58M 16.58M 16.58M 16.58M n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.47B 4.38B 4.19B 3.98B 3.86B 3.67B 3.5B 3.41B 3.27B 3.21B 3.14B 2.99B 2.83B 2.62B 2.41B 2.28B 2.08B
Income Tax Expense
123.69M 111.78M 166.56M 157.44M 156.63M 160.39M 141.35M 133.75M 133.94M 135.47M 32.06M 6.51M -7.58M -25.23M -33.41M -22.61M -23.86M
Shares Outstanding (Basic)
106.93M 105.29M 104.78M 104.78M 104.27M 104.08M 104.67M 104.63M 104.17M 103.76M 103.48M 102.8M 102.46M 95.03M 92.77M 91.85M 91.46M
Shares Outstanding (Diluted)
111.17M 105.29M 104.78M 104.78M 104.27M 104.08M 106.95M 104.63M 104.17M 103.76M 103.48M 102.8M 102.46M 95.03M 92.77M 91.85M 96.73M
EPS (Basic)
-48.49 -51.09 -57.98 -40.82 -29.51 -30.42 -35.49 -42.9 -44.85 -45.76 -21.32 -20.41 -20.02 -14.95 -14.04 -14.43 -13.52
EPS (Diluted)
-3.77 -6.24 -30.29 -27.17 -29.64 -30.55 -35.62 -42.9 -44.85 -45.76 -21.32 -20.41 -20.02 -15.08 -14.17 -14.56 -13.65
EBITDA
-150.1M -397.26M -728.05M -791.54M -1B -1.12B -1.21B -1.52B -1.65B -1.72B -1.83B -1.86B -1.9B -1.39B -1.31B -1.29B -1.18B
EBIT
-306.85M -568.2M -872.57M -886.27M -1.1B -1.21B -1.29B -1.6B -1.72B -1.79B -1.89B -1.92B -1.95B -1.44B -1.35B -1.33B -1.21B
Depreciation & Amortization
145.65M 170.94M 144.51M 94.73M 92.96M 87.67M 81.87M 76.56M 69.69M 66.28M 61.38M 57.36M 53.42M 46.46M 41.16M 37.33M 33.67M